Summary
The cost-of-illness studies of influenza performed in France for the years 1985 and 1989 have shown that the major economic consideration is the respective sizes of indirect and direct costs.
Depending on the point of view (from the perspective of National Health Insurance or the societal perspective) and the method used for measuring indirect costs, it was estimated that they could be between 1.5 and 9 times higher than direct costs.
A cost-benefit study of influenza vaccination for the employed adult population showed that vaccination is a cost-saving strategy, although this was also contingent upon the problems associated with measuring indirect benefits as well as the effectiveness rate of vaccination in real conditions.
Similar content being viewed by others
References
Lévy E, Lafarge H. L’evaluation du cout de la grippe dans la France contemporaine. April 1987: 41 (unpublished report)
Ministere de la Solidarite de la Sante et de la Protection Sociale Enquete de Morbidite Hospitaliere 1985-87. Fichessynthetiques par pathologies, in documents statistiques du SESI no. 89, mail, 1990
Drummond M. Cost of illness studies. A major headache? Pharmacoeconomics 1992; 2 (1): 1–4
Hodgson TA. Cost of illness on cost effectiveness analysis: a review of the methodology. Pharmacoeconomics 1994; 6 (6): 536–52
Lafarge H, Levy P. Deux evaluations du cout de la grippe. 1990: 25 (unpublished report)
Caisse Nationale d’Assurance Maladie des Travailleurs Salaries. Statistoques mensuelles. Resultats a fin Fevrier
Levy E, Levy P. La vaccination contre la grippe des personnes d’age actif (25-65 ans): une etude cout–benefice. Rev Epidemet Sante Publ 1992; 40: 285–95
Levy E. A cost–benefit study of influenza vaccination for 25 to 64 year old French people. In: Hannoun C, Kendal AP, Klenk HD, editors. Options for the control of influenza II. Amsterdam: Elsevier Science Publishing: 1993
Merlin M, Buisson Y. L’evaluation de l’efficacite de la vaccination antigrippale dans les armees au cours de l’hiver 1989-90,1990; BEH: 41
Les Comptes de la Nation 1989, INSEE, Paris: 1990
Couet C. Bilan demographique 1994,58 million d’inhabitants in INSEE Premiere no. 359; Paris, Fevrier: 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levy, E. French Economic Evaluations of Influenza and Influenza Vaccination. Pharmacoeconomics 9 (Suppl 3), 62–66 (1996). https://doi.org/10.2165/00019053-199600093-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199600093-00014